Published March 20, 2026 | Version v1
Dataset Open

ISCHEMIC STROKE: PATHOPHYSIOLOGY OF THE ISCHEMIC CASCADE, ETIOLOGICAL CLASSIFICATION, REPERFUSION STRATEGIES, NEUROPROTECTION, AND SECONDARY PREVENTION IN CONTEMPORARY NEUROLOGY

Authors/Creators

  • 1. Asia International University

Description

Conclusion: Ischemic stroke management has been transformed by acute reperfusion strategies with proven efficacy, but the narrow therapeutic time window demands stroke system organization—comprehensive stroke centers, pre-hospital triage protocols, and 24/7 thrombectomy capability—that remains incompletely developed in many healthcare systems. Secondary prevention through dual antiplatelet therapy, high-intensity statins, anticoagulation for atrial fibrillation, and aggressive vascular risk factor control offers the most durable means of reducing recurrent stroke risk.

Files

1499-1511.pdf

Files (394.7 kB)

Name Size Download all
md5:c54663676b9cdede14c32657b8ca2dae
394.7 kB Preview Download

Additional details

References

  • .Feigin, V. L., Norrving, B., & Mensah, G. A. (2017). Global burden of stroke. Circulation Research, 120(3), 439–448. https://doi.org/10.1161/CIRCRESAHA.116.308413
  • .Johnson, W., Onuma, O., Owolabi, M., & Sachdev, S. (2016). Stroke: A global response is needed. Bulletin of the World Health Organization, 94(9), 634–634A. https://doi.org/10.2471/BLT.16.181636
  • Dirnagl, U., Iadecola, C., & Moskowitz, M. A. (1999). Pathobiology of ischaemic stroke: An integrated view. Trends in Neurosciences, 22(9), 391–397. https://doi.org/10.1016/S0166-2236(99)01401-0
  • The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. (1995). Tissue plasminogen activator for acute ischemic stroke. New England Journal of Medicine, 333(24), 1581–1587. https://doi.org/10.1056/NEJM199512143332401
  • .Goyal, M., Menon, B. K., van Zwam, W. H., Dippel, D. W. J., Mitchell, P. J., Demchuk, A. M., ... & Jovin, T. G. (2016). Endovascular thrombectomy after large-vessel ischaemic stroke: A meta-analysis of individual patient data from five randomised trials. Lancet, 387(10029), 1723–1731. https://doi.org/10.1016/S0140-6736(16)00163-X